WW domain binding protein 2 pseudogene 1 (WBP2P1)

WW domain binding protein 2 pseudogene 1 (WBP2P1) is a human pseudogene, not a functional protein-coding gene. Pseudogenes such as WBP2P1 are characterized by their sequence similarity to coding genes—in this case, WW domain binding protein 2 (WBP2)[3][4]—but lack the ability to encode functional proteins due to mutations or truncations. Some pseudogenes have regulatory roles, such as producing noncoding RNAs that modulate the expression of related functional genes via RNA interference or by acting as microRNA decoys[2]. However, available data indicate that WBP2P1 does not encode a functional protein, and no direct evidence supports its role as a regulatory molecule, disease biomarker, or therapeutic target. This differentiates it from its parent gene, WW domain binding protein 2 (WBP2), which does have established roles in transcriptional coactivation and disease biology[3][4]. Summary of Key Points: - WBP2P1 is a pseudogene and not a therapeutic target; it does not encode a functional receptor, enzyme, or drug-interacting molecule[5]. - There is no evidence of direct therapeutic role, drug interaction, or significant biomarker function for patient selection associated with WBP2P1. - Entry may be misleading as a drug target due to confusion with its parent, WBP2, which is protein-coding and functionally significant, especially in cancer and auditory function[3][4][5].

Other names

hCG1643692WBP2P1